Get my own profile
Public access
View all61 articles
2 articles
available
not available
Based on funding mandates
Co-authors
- kathryn balmannoBabraham InstituteVerified email at babraham.ac.uk
- Matthew SaleUCSFVerified email at ucsf.edu
- Michael WakelamBabraham InstituteVerified email at babraham.ac.uk
- Pamela LochheadBabraham InstituteVerified email at babraham.ac.uk
- Martin McMahonCumming-Presidential Professor of Cancer Biology, Huntsman Cancer Institute, Univ. of UtahVerified email at hci.utah.edu
- Jim CauntLecturer, University of BathVerified email at bath.ac.uk
- Wolf ReikHead, Epigenetics Programme, Babraham Institute Cambridge, UKVerified email at babraham.ac.uk
- Miguel R BrancoBlizard Institute, QMUL, London, UKVerified email at qmul.ac.uk
- Llewelyn RoderickKULeuvenVerified email at kuleuven.be
- Myriam HembergerUniversity of Calgary, CanadaVerified email at ucalgary.ca
- Mona Bajaj-ElliottUniversity College LondonVerified email at ucl.ac.uk
- Sylvie GuichardExecutive Director Translational Medicine Novo NordiskVerified email at astrazeneca.com
- Julie WickendenPost-doctoral Researcher, University of CambridgeVerified email at horizondiscovery.com
- Scott NewmanGeneDxVerified email at sema4.com
- Gabriel NuñezPaul de Kruif Professor of Pathology, University of Michigan Medical SchoolVerified email at umich.edu
- Heather J LeeThe University of NewcastleVerified email at newcastle.edu.au
- Julia ArandPostdoctoral fellow, Medical University ViennaVerified email at meduniwien.ac.at
- Timothy A HoreGroup Leader, Department of Anatomy, University of OtagoVerified email at otago.ac.nz
- Ruth DenshamUniversity of BirminghamVerified email at bham.ac.uk
- Martin BootmancambridgeVerified email at open.ac.uk
Follow